Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disease affecting 1 in 1000 live births. ADPKD is caused by mutations in the PKD1 and PKD2 genes, and progresses to end-stage renal disease at a mean age of 55 years and 69 years, respectively [1] .
Early onset of hypertention occurs at a mean age of 31 years and a prevalence of 22% in pediatric population. Hypertension is strongly associated with hyperactivity of the renin-angiotensin-aldosterone system (RAAS), presenting in 60% of patients before the onset of renal insufficiency and representing a major risk factor for progression to renal failure and cardiovascular mortality [2] [3] [4] . Importantly, hypertension is also the most preventable and treatable condition associated with ADPKD [5] , and the control of hypertension obviously depends on using the most accurate and tolerable method of blood pressure monitoring.
The most common noninvasive methods of blood pressure monitoring include office (also called clinic) blood pressure monitoring (OBPM) using oscillometric or aneroid devices, self-measured home blood pressure monitoring (HBPM) using oscillometric devices, and 24-h ambulatory blood pressure monitoring (ABPM) using a computerized oscillometric device. OBPM represents the most commonly used method in clinical practice. Current guidelines for diagnosis and management of hypertension outlined in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure are based on OBPM with some reference to ABPM, but with little focus on self-measured HBPM [6] . However, whitecoat hypertension (office blood pressures readings higher than home readings) and masked hypertension (office blood pressures readings lower than home readings), which are present in up to 30% of participants, limit the use of OBPM [7] . Therefore, out-of-office blood pressure monitoring by ABPM or HBPM should play a significant role in the care of hypertension, and are often necessary. Importantly, HBPM and ABPM are more reproducible and reliable than OBPM [8] , and OBPM readings have been reported to be 7-17 mmHg higher for SBP and 5-14 mmHg higher for DBP compared with ABPM and HBPM. Whether circadian differences in blood pressure differ between out-of-office blood pressure measures is unclear; however, the difference between daytime ABPM and HBPM readings is insignificant [9] .
HBPM and ABPM predict end-organ damage (left ventricular hypertrophy, arterial stiffness index, and albuminuria) in essential hypertension and chronic kidney disease more reliably than OBPM [10, 11] . However, only ABPM provides an insight into the nocturnal and early morning variations of blood pressure. The lack of nocturnal drop in blood pressure or nondipping has been associated with end-organ damage including left ventricular hypertrophy, congestive heart failure, stroke, acute coronary events, microalbuminuria, decline in glomerular filtration rate (GFR), progressionto-end-stage renal disease, and all-cause mortality both in essential hypertension and ADPKD [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Despite these compelling data regarding home and ambulatory blood pressure predicting patient outcomes, Palatini et al. [22] reported poor reproducibility of the nocturnal dipping status in hypertensive patient populations. In a subsequent review of 12 studies, Parati and Staessen [23] showed a wide range of reproducibility rates of nocturnal dipping categorization (29.5-92%) in normotensive patients, treated and untreated hypertensive patients, type-I and type-II diabetic patients, and patients with chronic kidney disease. In ADPKD there is only one study comparing three sets of ABPM readings over 12 months, at least 3 months apart, in 30 hypertensive patients with ADPKD. This study showed a consistent dipping status in 43% of cases between two sets and 36.6% between the three sets of ABPM [24] . However, there were differences in therapeutic regimens (especially regarding the use of blockers of the RAAS) and significant changes in renal function due to the length of the study. Therefore, the use of what appears to be the main advantage of ABPM over HBPM remains uncertain in ADPKD population. Our study aimed to establish the short-term reproducibility of ABPM in treated hypertensive patients with ADPKD.
Materials and methods

Recruitment
We used the general infrastructure of the ongoing HALT-Polycystic Kidney Disease (PKD) trials for recruitment of the participants. Design and implementation of the HALT-PKD trials have extensively been detailed elsewhere [25] . In brief, the HALT-PKD trial is a combination of two concurrent randomized double-blinded and placebo-controlled trials evaluating the effect of multilevel blockade of the RAAS in hypertensive or prehypertensive patients with ADPKD, by using angiotensinconverting enzyme inhibitor alone vs. angiotensin-converting enzyme inhibitor plus an angiotensin receptor blocker. HBPM was the method of choice to guide therapeutic decisions regarding dose titration and addition of new antihypertensive agents. Figure 1 shows the place of ABPM within the general frame of the HALT-PKD trials.
We recruited 25 hypertensive patients at the Emory University and the Mayo clinic, Minnesota. Inclusion criteria were identical to that of the HALT-PKD participation criteria with additional inclusion and exclusion criteria such as providing informed consent, absence of allergic reaction to rubber (blood pressure cuff), absence of acute illnesses and absence of limited mobility (wheelchair bound or bedridden), absence of night-shift working, and completion of the titration phase of the HALT-PKD trial, and on a stable antihypertensive regimen. This study protocol was approved by the steering committee of the HALT-PKD trial and the Institutional Review Boards of the Emory University and the Mayo Foundation. All potential participants underwent informed consent before study initiation.
Ambulatory blood pressure monitoring procedures
Spacelab-90207 monitors (Spacelabs, Redmond, Washington, USA; approved by the British Society of Hypertension and the American Association for Medical Instrumentations) were used for ABPM. The two sets of ABPM were obtained under similar conditions, that is, 7-15 days apart. Place of the pilot ambulatory blood pressure monitoring (ABPM) study in the HALT-PKD trial. BP, blood pressure; eGFR, estimated glomerular filtration rate; HBPM, home blood pressure monitoring; OBPM, office blood pressure monitoring.
The appropriate cuff size was used on the nondominant arm. Patients were instructed to avoid removing the monitor, showering, bathing, and engaging in vigorous exercise. Blood pressure readings were measured every 20 min during the day (06:00-21:59 h) and every 30 min during the night (22:00-05:59h). In case of first unsuccessful attempt, the monitor made three additional attempts to record a blood pressure reading. For each participant, ABPMs were performed on both either a similar working or a nonworking day. Physical activity, stress, and the time of falling asleep and waking up were recorded in a diary. We did not eliminate the transition hour data points. ABPM was considered adequate if it contained more than 50 blood pressure readings, with at least one measurement every hour and less than 10% erroneous or repeated reading.
Data from ABPM were retrieved and transcribed into Excel format. Demographical and medical data were retrieved from the main HALT-PKD trial database. The HALT-PKD Data Coordinating Center monitored the integrity of study procedures on an annual basis.
Data analysis and statistical methods
The average daytime and night-time SBP and DBP were defined as the mean of readings over the day and night periods. Mean arterial pressure (MAP) was defined as DBP + [(SBP -DBP)/3]. Heart rate was defined as the number of heart beats per minute during blood pressure measurements. Pulse pressure was defined as the difference between SBP and DBP. Nocturnal dipping was defined as a Night:Day (N:D) ratio of SBP and DBP of less than 0.9 and nondipping as a ratio of at least 0.90.
A sample size of 25 participants was determined to be adequate to have 80% power to detect any correlation greater than 0.4 between SBP, DBP, and dipping status comparing the two sets of ABPM, at a significance level alpha 0.05.
Correlation and concordance coefficients between days 1 and 2 were calculated for the following parameters: SBP, DBP, MAP, heart rate, pulse pressure, and the N:D or Asleep:Awake (A:A) ratio of SBP and DBP difference between days 1 and 2. Concordance coefficient (r c ) is defined as:
where m x and m y are the means for the two variables and s 2 x and s 2 y are the corresponding variances. Rho (r) is the correlation coefficient between the two variables. Concordance coefficients are more appropriate for reproducibility studies as they represent the spread of the data points around the line of identity whereas correlation coefficients compare them with a regression line [26] .
The reproducibility of dipping status was determined by estimating the proportion of patients who remained in the same dipping category. Cohen's Kappa statistics were used to compare those proportions [27] . We also considered the N:D and A:A ratios of SBP and DBP as continuous variables and calculated Pearson's correlation coefficients and concordance coefficients for each measure by comparing the differences obtained on days 1 and 2. Univariate analysis using either Fisher's exact test or Wilcoxon test was carried out to look for potential associations between consistency of dipping and predictor variables. Finally, we carried out univariate analysis between D:N and A:A ratios of SBP and DBP and different predictor variables. Owing to the number of participants (n = 25), logistic or linear regression was not deemed to be applicable. All data analysis was carried out using SAS 9.2 (SAS Institutes Cary, North Carolina, USA).
Results
Twenty-nine participants (22 at the Emory University and seven at the Mayo clinic) were consented. One participant could not tolerate the blood pressure cuff, two participants only completed one set of ABPM, and one participant had an inadequate number of readings. Twenty-five participants successfully completed two sets of ABPM. Characteristics of the four participants who were not included in the analysis did not differ from the study cohort (data not shown).
The cohort consisted of middle-aged (mean age: 43.1 years), nonsmoking (96%), Caucasian participants (92%), with a slight predominance of women (52%) ( Table 1) . Renal function was fairly well preserved [mean serum creatinine was 1.29 mg/dl and mean estimated GFR (eGFR) was 63 ml/min/1.73 m 2 ]. Duration of hypertension was 9.6 years and blood pressure was extremely well controlled at the time of enrollment into this study (mean SBP and DBP were 113.6 and 71.7 mmHg, respectively).
Blood pressure readings were similar between days 1 and 2, both by fixed clock and Asleep-Awake separation of day and night ( . MAP and pulse pressure declined similarly between days 1 and 2 whereas heart rate did not show a nocturnal decline in either study days. We found a strong correlation and concordance between days 1 and 2 regardless of the used method to separate day and night (coefficients were all above 0.79, except for heart rate) ( Table 3) .
On the basis of fixed clock separation, eleven participants (44%) were nondippers on both days, six (24%) were dippers on both days, three (12%) were nondippers on day 1 and became dippers on day 2, and five (20%) were dippers on day 1 and became nondippers on day 2. The ratios were slightly different for Asleep-Awake separation as 10 patients (40%) were consistent dippers and eight (32%) patients were consistent nondippers. Furthermore, there were two (8%) reverse-dippers in the nondipper group (one consistently and the other one inconsistently). Overall, 17 of the 25 (68%) and 18 of the 25 (72%) patients stayed in the same dipping category based on N:D or Asleep-Awake categorizations, whereas eight of the 25 (32%) and seven of the 25 (28%) patients changed their dipping status ( Table 4 ). The Cohen's Kappa coefficient was 0.34 and (asymptotic standard error = 0.18, two-sided probability of Kappa equal zero = 0.09) for N:D ratio and 0.36 for A:A ratio (asymptotic standard error = 0.178, two sided probability of Kappa equal zero = 0.0473) (see Table 4 ).
Univariate analyses did not show any significant associations between the dipping consistency (using both N:D and A:A ratios) and eGFR, age, duration of hypertension, SBP or DBP at the end-of-titration visit in HALT, urine aldosterone levels, BMI, caffeine consumption, sex, and smoking or race (Table 5 ). When N:D ratios were Table 2 Comparison of blood pressure readings between days 1 and 2 during day and night considered as continuous variables, Pearson's correlation coefficient and concordance coefficients were 0.58 and 0.56 for SBP and 0.56 and 0.54 for DBP, respectively (Fig. 2) . Table 6 shows means and SD values for the ratios whereas Fig. 2 only shows the correlation coefficients. The coefficients were higher for SBP and lower for DBP using the A:A ratio. No significant associations with any of the earlier reported covariates were found.
Discussion
The increasing use of HBPM requires the questioning of the role of ABPM for nonoffice based blood pressure monitoring. Advantages of HBPM include cost-effectiveness, good prediction of cardiovascular outcomes, strong correlation with daytime ABPM, and the increased compliance with antihypertensive regimens when home monitoring is used [28] [29] [30] . The main advantages of ABPM over HBPM include additional blood pressure readings, and insight into the diurnal variations of blood pressure including nocturnal dipping and the early morning surge. Both have both been associated with worse cardiovascular outcomes [31] . The predictive power of nocturnal dipping on cardiovascular outcomes has been established from longitudinal studies, such as the Ohasama study [32] where each 0.05 increment in N:D ratio of SBP or DBP corresponded to a 20% increased risk of cardiovascular death, even when blood pressure was below 135/80. However, reproducibility of nocturnal dipping in ADPKD has been controversial. Thus far, evidence suggests that ABPM is superior to OBPM in diagnosing masked hypertension and prehypertensive state in ADPKD [33] and positive correlations between average 24 h SBP and left ventricular mass index exist in normotensive and hypertensive patients with ADPKD [19] . Importantly, patients with ADPKD also show lower amplitude of the nocturnal decline and a higher frequency of nondipping than essential hypertensive patients [21] . Therefore, the significance and reproducibility of nondipping and the comparative place of ABPM and HBPM are extremely important to establish in this patient population.
Our study is the first to compare two sets of ABPM over a relatively short interval (7-15 days) in a hypertensive (or prehypertensive) population with ADPKD with relatively uniform clinical characteristics and on stable antihypertensive regimens. Of note, all patients were either hypertensive (BP > 130/80) or had been on antihypertensive agents before screening visit of the HALT-PKD trial. We confirmed an excellent correlation between mean SBP, DBP, MAP, and heart rate between the 2 days of measurement and established that the majority (56-64%) of our patients with ADPKD are nondippers, with a small proportion (8%) showing reverse dipping. Reverse dipping is typically present in approximately 11% of the population with essential hypertension and is associated with a fivefold increase in cardiovascular mortality compared with Table 6 Correlation coefficients for Night:Day and Asleep:Awake ratios between days 1 and 2 Pearson's correlation coefficient r = 0.56 dippers [34] . Of note, the frequency of nondipping in essential hypertension is between 25 and 42%, based on a single measurement [35] , significantly less than the frequency found in this relatively healthy population with ADPKD.
We observed a 68 and 72% consistency rate for nocturnal dipping status based on fixed clock and Asleep-Awake status. These values are similar to studies in essential hypertension [36] and in contrast with the previously reported 36.6-44% [24] . Importantly, in earlier studies, measurements were obtained over a longer period (12 months) in a heterogenous population with ADPKD and with variable hypertension status and changing antihypertensive medication regimens.
We chose the most restrictive definition of dipping (N:D and A:A ratios of both SBP and DBP drops > 0.9) as a comparative study showed a slightly better reproducibility rate by using both SBP and DBP when compared with MAP or DBP alone [37] . The lack of uniformity in definitions has been proposed as a possible explanation for lack of reproducibility of the dipping status in many studies [37, 38] . Multiple other definitions were considered, however the definitions chosen for this study allow for application to a general population with ADPKD and addresses the inherent interindividual variability of daily life. We compared results using the fixed-hour separation of day and night (06:00-21:59 h vs. 22:00-05:59 h) with the self-reported Asleep-Awake times and the results were very similar and consistent with the uneventful diaries in the majority of our patients. In addition, by design, we tried to minimize the influence of known factors that may affect the nocturnal dipping (day of the week, antihypertensive medication regimen, lapse of time between the two measurements, severely limited mobility making patients bedridden, and night-shift workers).
We could not identify any associations between dipping status (or consistency of dipping) and reported variables such as race, sex, age, renal function, and caffeine intake. This may be due to the small number of participants but could also be due to a misclassification error (ratios of N:D blood pressure of 0.8999 vs. 0.901 changed the dipping status) and the unusually low blood pressure targets that were achieved in the HALT-PKD trial by using the blockers of the RAAS, where half of the patients were additionally assigned to a blood pressure level of less than 110 by 75 mmHg and the other half to 120-130 by 70-80 mmHg. We intentionally excluded 'blood pressure load' analysis in our study due to the unusually low-blood pressure load imposed by the blood pressure targets of the clinical trial [39] . Sample size may directly affect the strength of the presented evidence and may also prevent us from using logistic or linear regression models to further elucidate possible explanations for variability of dipping. External validity of our results is limited due to lack of racial diversity and exclusion of advanced renal insufficiency (chronic kidney disease stages IV and V, eGFR of less than 25).
Relationship between consistent dipping on at least two occasions or dipping over 48 h and target organ damage outcomes needs to be investigated in the population with ADPKD as the first pattern has been associated with greater cardiac abnormalities than variable dipping in untreated hypertensive patients [40] whereas the second pattern has been associated with a dramatic 89% consistency of dipping [41] . Therefore 'double dipping' defined as either consistent dipping on more than one occasion or over 48 h may provide a better risk stratification than 'single dipping' and should therefore be investigated in the population with ADPKD.
Finally, determination of the role of biological factors that may influence day-to-day inconsistency of the dipping status such as urinary sodium excretion [42] , neurohormonal regulation of blood pressure sympathetic nervous activity, endothelial dysfunction, dietary factors (i.e. potassium intake), and compliance issues with medications should all be considered [43] [44] [45] [46] .
Conclusion
We conclude that ABPM measurements of SBP, DBP, MAP, and heart rate are strongly reproducible in optimally treated hypertensive (or prehypertensive) patients with ADPKD for over 7-15 days. Nondipping is predominant in this population with relatively conserved renal function and an excellent control of blood pressure by using the blockers of the RAAS. Reproducibility of nondipping is best at moderate. Variability of dipping status may reflect biological changes rather than measurement errors. Future research is warranted to elucidate these factors and also to determine an optimal ABPM regimen, including repeated or longer measurements of ABPM, for a better prediction of cardiovascular and renal outcomes in ADPKD.
